Showing 1,281 - 1,300 results of 2,338 for search 'Atlus~', query time: 1.57s Refine Results
  1. 1281
  2. 1282
  3. 1283
  4. 1284

    Patients' lives don't pause for blanking periods by Mohammed Ruzieh, John M Mandrola, Andrew J Foy

    Published 2025-02-01
    “…American Heart Journal Plus…”
    Get full text
    Article
  5. 1285
  6. 1286
  7. 1287
  8. 1288
  9. 1289
  10. 1290
  11. 1291
  12. 1292
  13. 1293
  14. 1294
  15. 1295
  16. 1296

    New Bipolar Electrosurgical Vessel Sealing Device Provides Improved Performance and Procedural Efficiency by Chambers R, Sarno D, Roweton S

    Published 2025-01-01
    “…Rheagan Chambers, Danielle Sarno, Susan Roweton Surgical Research and Development, Surgical Operating Unit, Medtronic, Lafayette, CO, USACorrespondence: Susan Roweton, Email susan.roweton@medtronic.comPurpose: This study compared the performance of the new LigaSure™ XP Maryland Jaw Sealer/Divider (XP Maryland) to that of LigaSure Atlas™ (Atlas) and LigaSure™ Dolphin Tip (Dolphin Tip), two early LigaSure™ (LigaSure) devices characterized by consistent and reliable clinical performance.Methods: Ex vivo bench testing on porcine renal arteries compared burst pressures, seal times, and rates of sticking, incomplete cuts, and charring between XP Maryland and Atlas and between XP Maryland and Dolphin Tip. …”
    Get full text
    Article
  17. 1297

    Morphological and Anatomical Characterization of Ecotype Needles of Cedrus atlantica in Morocco by Nezha El Bakkali, Mohammed Bendriss Amraoui

    Published 2022-01-01
    “…Atlas cedar (Cedrus atlantica (Endl.) G. Manetti ex Carrière) is an endemic species in the mountains of North Africa that is attracting international interest in its use in the reforestation of degraded ecosystems. …”
    Get full text
    Article
  18. 1298
  19. 1299

    Dynamics of blood microsatellite instability (bMSI) burden predicts outcome of a patient treated with immune checkpoint inhibitors: a case report of hyperprogressive disease by Daria Kravchuk, Alexandra Lebedeva, Alexandra Lebedeva, Olesya Kuznetsova, Olesya Kuznetsova, Alexandra Kavun, Anastasiia Taraskina, Ekaterina Belova, Ekaterina Belova, Ekaterina Belova, Tatiana Grigoreva, Tatiana Grigoreva, Egor Veselovsky, Vladislav Mileyko, Vladislav Mileyko, Vladislav Nikulin, Lidia Nekrasova, Alexey Tryakin, Mikhail Fedyanin, Mikhail Fedyanin, Mikhail Fedyanin, Maxim Ivanov, Maxim Ivanov

    Published 2025-02-01
    “…Sequential sampling of the patient’s plasma demonstrated an increase in MSI burden (bMSI), which was found to correlate with the increase of driver mutation burden one month after starting nivolumab, and hyperprogressive disease. Thus, analysis of bMSI in liquid biopsy via NGS may be a promising method for timely assessment of the treatment effectiveness received by patients with MSI-positive CRC.…”
    Get full text
    Article
  20. 1300

    Management of Recurrent Ventriculoperitoneal Shunt Infections in Adult Patients by Neval Elgormus, Yusuf Elgormus, Bagnu Dundar, Fatma Bozkurt, Huseyin Dogu, Hafize Uzun

    Published 2025-01-01
    “…<b>Conclusions:</b> Based on the findings of our study, it is essential to closely monitor patients with independent risk factors for RVPS infection development, due to the high rates of resistant Gram-negative bacterial growth and the initiation of empirical antimicrobial treatment with glycopeptide plus carbapenem. Certain treatment options, such as 3GCs plus glycopeptide, should be revised based on clinical progress and microbiological culture results.…”
    Get full text
    Article